Barriers to Misoprostol Use in Developing Countries

Posted on

By: Sarah Hodin, Project Coordinator II, Women and Health Initiative, Harvard T.H. Chan School of Public Health

Where oxytocin is not readily available for post-abortion care and postpartum hemorrhage prevention, misoprostol is the recommended alternative. Nevertheless, many countries have not been able to ensure access to safe misoprostol use to prevent maternal deaths due to several barriers…read more